Tower Research Capital LLC (Trc) Corcept Therapeutics Inc Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,109 shares of CORT stock, worth $566,944. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,109

Previous 1,729 426.84%

Holding current value

$566,944

Previous $79,000 481.01%

% of portfolio

0.01%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$44.66 - $60.85 $329,590 - $449,073	7,380 Added 426.84%	9,109 $459,000
Q3 2024 Nov 14, 2024	SELL	$29.51 - $46.26 $252,399 - $395,661	-8,553 Reduced 83.18%	1,729 $79,000
Q2 2024 Aug 13, 2024	BUY	$22.21 - $34.48 $129,217 - $200,604	5,818 Added 130.33%	10,282 $334,000
Q1 2024 May 15, 2024	SELL	$21.1 - $27.46 $565,100 - $735,433	-26,782 Reduced 85.71%	4,464 $112,000
Q4 2023 Feb 13, 2024	BUY	$24.82 - $32.88 $642,068 - $850,572	25,869 Added 481.1%	31,246 $1.01 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $79,992 - $123,065	3,641 Added 209.74%	5,377 $146,000
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $37,219 - $43,660	1,736 New	1,736 $38,000
Q4 2022 Feb 10, 2023	SELL	$19.95 - $29.96 $82,852 - $124,423	-4,153 Reduced 89.49%	488 $10,000
Q3 2022 Nov 10, 2022	BUY	$24.7 - $29.12 $33,419 - $39,399	1,353 Added 41.15%	4,641 $119,000
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $31,731 - $46,324	-1,831 Reduced 35.77%	3,288 $78,000
Q1 2022 May 12, 2022	BUY	$16.53 - $25.21 $4,446 - $6,781	269 Added 5.55%	5,119 $116,000
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $39,894 - $54,452	2,333 Added 92.69%	4,850 $96,000
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $193,769 - $221,830	-9,846 Reduced 79.64%	2,517 $49,000
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $35,686 - $43,656	1,787 Added 16.9%	12,363 $272,000
Q1 2021 May 17, 2021	BUY	$23.49 - $30.56 $173,121 - $225,227	7,370 Added 229.88%	10,576 $252,000
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $1.13 Million - $1.85 Million	-67,597 Reduced 95.47%	3,206 $84,000
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $714,867 - $1.15 Million	57,373 Added 427.2%	70,803 $1.23 Million
Q2 2020 Aug 13, 2020	BUY	$11.0 - $18.26 $147,730 - $245,231	13,430 New	13,430 $226,000
Q4 2019 Feb 07, 2020	SELL	$12.06 - $16.96 $16,546 - $23,269	-1,372 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$10.41 - $14.66 $7,214 - $10,159	693 Added 102.06%	1,372 $19,000
Q2 2019 Aug 13, 2019	BUY	$9.78 - $12.76 $6,640 - $8,664	679 New	679 $8,000
Q3 2018 Nov 13, 2018	SELL	$12.27 - $15.65 $19,325 - $24,648	-1,575 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$15.3 - $19.69 $15,942 - $20,516	1,042 Added 195.5%	1,575 $25,000
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $7,776 - $13,591	533 New	533 $9,000
Q4 2017 Feb 09, 2018	SELL	$15.77 - $20.72 $163,960 - $215,425	-10,397 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $127,883 - $200,662	10,397	10,397 $201,000

Others Institutions Holding CORT

# of Institutions

414

Shares Held

84.9M

Call Options Held

1.04M

Put Options Held

1.33M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.67B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Corcept Therapeutics Inc Transaction History